Cardiometabolic Rx: Part 1: Metabolic foundations and myths
About this episode
The episode discusses the foundations of cardiometabolic health and challenges common myths while providing evidence-based strategies for practitioners.
In part 1 of the Cardiometabolic Rx podcast, host Emma Sutherland is joined by Dr Adrian Lopresti, Dr Michelle Woolhouse, Lisa Costa-Bir, and Mick Alexander for a wide-ranging discussion on the foundations of cardiometabolic health. Together, they explore how individualised nutrition, hormonal balance, stress adaptation, and muscle and bone integrity as well as kidney health influence metabolic outcomes, emphasising why truly integrative care must extend beyond BMI, cholesterol and blood pressure checks. The panel shares the latest evidence on emerging assessment tools - including continuous glucose monitoring, homocysteine and trimethyl amine and oxide (TMAO) testing, and the body roundness index and how these measures can reveal early signs of dysfunction before overt disease develops. In an engaging exchange of clinical perspectives, the ambassadors uncover the “silent hijackers” of cardiometabolic health such as poor sleep, loneliness, medications, and gut dysbiosis. This thought-provoking discussion challenges long-held assumptions and equips practitioners with practical, evidence-based strategies to assess and address cardiometabolic risk at every stage of patient care…
More episodes of FX Medicine Podcast Central
- The biology of sustainable weight loss with Emma Sutherland and Dr Nick Fuller
- REPLAY: Exercise, training & the influence of female sex hormones with Lisa Costa-Bir & Dr Stacy Sims
- REPLAY: Cardiovascular health in pregnancy and postpartum
- Cardiometabolic Rx: Part 2: Interventions and innovations
- Androgens in women: From excess to sensitivity with Emma Sutherland and Lara Briden
- Continuous glucose monitoring with Dr Michelle Woolhouse and Dr Jessica Turton
Explore listener stats, chart rankings, contacts and more on the FX Medicine Podcast Central podcast page.